Journal
EJNMMI RESEARCH
Volume 11, Issue 1, Pages -Publisher
SPRINGER
DOI: 10.1186/s13550-021-00802-w
Keywords
Auger electrons; Tl-201; Thallium-201; Radiobiology; Targeted molecular radionuclide therapy
Funding
- UK Research and Innovation Medical Research Council Doctoral Training Partnership [MR/N013700/1]
- Theragnostics Ltd.
- Rosetrees Trust [M786]
- Engineering and Physical Sciences Research Council (EPSRC) [EP/S032789/1]
- Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z]
- Wellcome Trust [WT 203148/Z/16/Z]
- National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London
- EPSRC [EP/S032789/1] Funding Source: UKRI
Ask authors/readers for more resources
Thallium-201 (Tl-201) has potential therapeutic effects on cancer cells when internalized, reducing clonogenic survival and increasing nuclear DNA damage. Further development and evaluation of Tl-201 therapeutic radiopharmaceuticals are justified based on these findings.
Background Auger electron-emitting radionuclides have potential in targeted treatment of small tumors. Thallium-201 (Tl-201), a gamma-emitting radionuclide used in myocardial perfusion scintigraphy, decays by electron capture, releasing around 37 Auger and Coster-Kronig electrons per decay. However, its therapeutic and toxic effects in cancer cells remain largely unexplored. Here, we assess Tl-201 in vitro kinetics, radiotoxicity and potential for targeted molecular radionuclide therapy, and aim to test the hypothesis that Tl-201 is radiotoxic only when internalized. Methods Breast cancer MDA-MB-231 and prostate cancer DU145 cells were incubated with 200-8000 kBq/mL [Tl-201]TlCl. Potassium concentration varied between 0 and 25 mM to modulate cellular uptake of Tl-201. Cell uptake and efflux rates of Tl-201 were measured by gamma counting. Clonogenic assays were used to assess cell survival after 90 min incubation with Tl-201. Nuclear DNA damage was measured with gamma H2AX fluorescence imaging. Controls included untreated cells and cells treated with decayed [Tl-201]TlCl. Results Tl-201 uptake in both cell lines reached equilibrium within 90 min and washed out exponentially (t(1/2) 15 min) after the radioactive medium was exchanged for fresh medium. Cellular uptake of Tl-201 in DU145 cells ranged between 1.6 (25 mM potassium) and 25.9% (0 mM potassium). Colony formation by both cell lines decreased significantly as Tl-201 activity in cells increased, whereas Tl-201 excluded from cells by use of high potassium buffer caused no significant toxicity. Non-radioactive TlCl at comparable concentrations caused no toxicity. An estimated average Tl-201 intracellular activity of 0.29 Bq/cell (DU145 cells) and 0.18 Bq/cell (MDA-MB-231 cells) during 90 min exposure time caused 90% reduction in clonogenicity. Tl-201 at these levels caused on average 3.5-4.6 times more DNA damage per nucleus than control treatments. Conclusions Tl-201 reduces clonogenic survival and increases nuclear DNA damage only when internalized. These findings justify further development and evaluation of Tl-201 therapeutic radiopharmaceuticals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available